manufacturer_name | ndc_number | drug_product_description | date_introduced_to_market | wac_at_introduction | marketing_pricing_plan_description | marketing_pricing_plan_non_public_indicator | estimated_number_of_patients | breakthrough_therapy_indicator | priority_review_indicator | acquisition_date | acquisition_price | acquisition_price_non_public_indicator | acquisition_price_comment | general_comments | supporting_documents |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
XGen Pharmaceuticals DJB | 39822065001 | Nelarabine Injection 250mg/50mL Vial | 2025-02-17 | 350.0000 | None | 1 | 500 | None | None | None | None | None | None | None | None |
XGen Pharmaceuticals DJB | 39822065006 | Nelarabine Injection 250mg/50mL x 6 | 2025-02-17 | 2100.0000 | None | 1 | 500 | None | None | None | None | None | None | None | None |